Vasoconstrictors. Class Summary. These agents are used in medical management of portal hypertension. They reduce portal ... Choleretic agents. Class Summary. These agents enhance bile salt-dependent biliary flow. These may prove to be a valuable ...

Metaraminol is a potent sympathomimetic amine that increases both systolic and diastolic blood pressure. Metaraminol is indicated for prevention and treatment of the acute hypotensive state occurring with spinal anesthesia. It is also indicated as adjunctive treatment of hypotension due to hemorrhage, reactions to medications, surgical complications, and shock associated with brain damage due to trauma or tumor. Metaraminol acts on both α1-adrenergic receptors but appears to have no effect on β-adrenergic receptors. It acts by increasing the force of the hearts pumping action as well as constricting peripheral blood vessels ...

Cocaine is absorbed from all sites of application, including mucous membranes and gastrointestinal mucosa. By oral or intra-nasal route, 60 to 80% of cocaine is absorbed ...

vasoconstrictor agent Drug used to cause constriction of the blood vessels.. sympathomimetic agent A drug that mimics the ... R)-noradrenaline (CHEBI:18357) has role vasoconstrictor agent (CHEBI:50514) (R)-noradrenaline (CHEBI:18357) is a noradrenaline ... An agent that selectively binds to and activates alpha. -adrenergic receptors.. mouse metabolite Any mammalian metabolite ... sympathomimetic agent A drug that mimics the effects of stimulating postganglionic adrenergic sympathetic nerves. Included in ...

Further characterization of ideal dosing, timing, and agent selection should be investigated on a larger scale format. ... Vasoconstrictor Agents / administration & dosage* * Vasoplegia / diagnosis * Vasoplegia / drug therapy* * Vasoplegia / ... Further characterization of ideal dosing, timing, and agent selection should be investigated on a larger scale format. ...

ISBN 978-0-07-136704-2. Yagiela JA (1995). "Vasoconstrictor agents for local anesthesia". Anesthesia Progress. 42 (3-4): 116- ... which is usually water-based or just sterile water Vasoconstrictor possibly (see below) Reducing agent (antioxidant), e.g. if ... the maximum doses of LAs when combined with a vasoconstrictor is higher compared to the same LA without any vasoconstrictor. ... Local anesthetics and vasoconstrictors may be administered to pregnant patients however it is very important to be extra ...

Vasoconstrictor Agents / therapeutic use * Vasodilator Agents / therapeutic use Substances * Blood Glucose * Diuretics ...

Common Local Anesthetic Agents and Vasoconstrictors Lidocaine 1:50,000. Term. Definition. Common trade name of Lidocaine.. ... Amount of anesthetic agent (mg/ml) of Lidocaine. 20mg/ml. Amount of anesthetic agent per carpule (mg/cartridge) of Lidocaine.. ... Amount of vasoconstrictor per cartridge (mg) in Lidocaine. 0.036mg. Maximum recommended dose Vasocontrictor per appointment in ... Maximum dose of anesthetic agent (mg/lb body weight). 2mg/lb. Maximum recommended dose anesthetic per appointment of Lidocaine. ...

Inotropic agents and vasoconstrictors. Dopamine (high dose). ,10 mcg/kg/min. Alpha, beta 1, dopamine ... the inadequate tissue perfusion is caused by loss of the normal responses of vascular smooth muscle to vasoconstrictive agents ... impaired microvascular response to endogenous vasoconstrictors such as norepinephrine) and myocardial function (direct ...

This is a "connection" page, showing publications Sonal Singh has written about Vasoconstrictor Agents. ...

This overview of injectable agents in dental anesthesia may be useful for nonsurgical periodontal therapy procedures. ... Agents with 1:200,000 epinephrine may be useful when it is necessary to limit vasoconstrictor dose (see Tables 2 and 3).1-3 The ... Agents and vasoconstrictors. All injectable dental local anesthetics available in North America today are amide local ... Vasoconstrictors are added to local anesthetic agents to counteract the vasodilatory properties. By constricting the blood ...

Because of this proximity, avoid adding vasoconstrictors to the anesthetic agent.. * Use the previously described landmarks to ... Most local anesthetic agents share the same basic chemical structure, which consists of an aromatic ring, linked to an ... Bupivacaine (Marcaine) is another frequently used anesthetic agent.. *. The onset of action of bupivacaine is slower than that ... The chemical structure of this intermediate group classifies the agent into the amide group or the ester group. This structural ...

Use local anesthetic agents containing a vasoconstrictor congruent with the patients functional capacity ...

A combination of anesthetic agents and local vasoconstrictors is needed. We present customary technical characteristics of ... A combination of anesthetic agents and local vasoconstrictors is needed. We present customary technical characteristics of ... and a combination of anesthetic agents and local vasoconstrictors is needed. As a matter of fact, local scalp blocks are common ... It is a short-acting, amide agent and its onset takes place 2 min after injection. The effects are 1-2 h long but the ...

Sympathomimetic, vasoconstrictor agent.. Droxidopa. A medication used to treat symptomatic neurogenic orthostatic hypotension ( ...

Because of this proximity, avoid adding vasoconstrictors to the anesthetic agent.. * Use the previously described landmarks to ... Most local anesthetic agents share the same basic chemical structure, which consists of an aromatic ring, linked to an ... Bupivacaine (Marcaine) is another frequently used anesthetic agent.. *. The onset of action of bupivacaine is slower than that ... The chemical structure of this intermediate group classifies the agent into the amide group or the ester group. This structural ...

Part I: Drugs 1. Neurophysiology 2. Pharmacology of Local Anesthetics 3. Pharmacology of Vasoconstrictors 4. Clinical Action of ... Specific Agents. Part II: The Armamentarium 5. The Syringe 6. The Needle 7. The Cartridge 8. Additional Armamentarium 9. ...

Vasoconstrictor Agents (MeSH) published in * BMJ Open Journal Research. keywords * Fluid Therapy ... Although excessive vasoconstriction may be harmful, these agents may help reduce administration of potentially harmful ...

Introduces chemical agents in periodontal care, periodontal surgical procedures, periodontal maintenance and emergencies. ... Rationale for pain control; neuroanatomy; neurophysiology; pharmacology of local anesthetics and vasoconstrictors; non- ... injectable and injectable anesthetic agents; local and systemic complications; medical emergencies; patient assessment; and ...

Moreover, the concurrent use of vasoconstrictor agents such as ergot alkaloids, nicotine, and sumatriptan with Sansert results ...

An increase in blood pressure achieved using vasoconstrictor agents in hypovolemic patients does not provide adequate organ ...

... upon various factors such as the site of administration and the presence or absence of a vasoconstrictor agent. Except for ... Disinfecting agents containing heavy metals, which cause release of respective ions (mercury, zinc, copper, etc.) should not be ... Preparations containing a vasoconstrictor should be used with caution in patients during or following the administration of ... Allergic reactions may occur as a result of sensitivity either to local anesthetic agents or to the methylparaben used as a ...

"Vasoconstrictor agents should be used in local anesthesia solutions during dental practice only when it is clear that the ... 5.3 Vasoconstrictor Toxicity. ZORCAINE contains epinephrine, a vasoconstrictor that can cause local or systemic toxicity and ... Vasoconstrictor Toxicity: Local anesthetic solutions like ZORCAINE that contain a vasoconstrictor should be used cautiously, ... 5.3 Vasoconstrictor Toxicity 5.4 Methemoglobinemia 5.5 Anaphylaxis and Allergic-Type Reactions 6 ADVERSE REACTIONS 6.1 Clinical ...

... selectively infused vasoconstrictor agents, or a combination of these techniques. Up to 95% of patients can obtain initial ...

This paradoxical response (vasodilation in some vascular beds) distinguishes it from other vasoconstrictor agents. The infant ... This paradoxical response (vasodilation in some vascular beds) distinguishes it from other vasoconstrictor agents. The infant ... This paradoxical response (vasodilation in some vascular beds) distinguishes it from other vasoconstrictor agents. The infant ... This paradoxical response (vasodilation in some vascular beds) distinguishes it from other vasoconstrictor agents. The infant ...

Therapies such as clonidine, a centrally acting α2-agonist and sympatholytic agent, and the use of vasoconstrictors such as ...

... responsiveness of tail artery to vasoconstrictor or vasodilatory agents, and heart rate and blood pressure in response to ... Vasoactive-agents; Cellular-reactions; Heart-rate; Blood-pressure ...

Vasoconstrictor Agent Pharmacology, Toxicology and Pharmaceutical Science 71% * Temperature Biochemistry, Genetics and ... The reduction in perfusion is used as a measure for vasoconstrictor sensitivity at maximal vasoconstrictor tone. This is ... The reduction in perfusion is used as a measure for vasoconstrictor sensitivity at maximal vasoconstrictor tone. This is ... The reduction in perfusion is used as a measure for vasoconstrictor sensitivity at maximal vasoconstrictor tone. This is ...

An adrenergic vasoconstrictor agent used as a decongestant.. Terms. Naphazoline Preferred Term Term UI T027692. Date01/01/1999 ... An adrenergic vasoconstrictor agent used as a decongestant.. Entry Term(s). AK-Con Afazol Grin Albalon All Clear Clear Eyes ... 91; was see under IMIDAZOLES 1975-90; was see under VASOCONSTRICTOR AGENTS, NASAL 1967-74; was see under SYMPATHOMIMETICS 1963- ... 91(63); was see under IMIDAZOLES 1975-90; was see under VASOCONSTRICTOR AGENTS, NASAL 1967-74; was see under SYMPATHOMIMETICS ...

... pharmacologic agents that do not contain blood components or fractions such as vasoconstrictors, agents that enhance ...